Skip to content

To study role of oral zinc in pneumonia

Effect of oral zinc supplementation as an adjunct in the treatment of pneumonia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014968
Enrollment
130
Registered
2018-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pneumonia

Interventions

Intervention1: oral zinc: GROUP A:Patients will receive oral zinc gluconate in liquid formulation containing 20 mg elemental zinc in each 5 ml of solution,10 mg (2.5ml) in patients less than 6 months

Sponsors

Dr Kashmira Rajesh Mutha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hospitalized children from age 2 months till 12 years 2.Diagnosed as pneumonia based on following criteria: A.Fever, cough, difficulty in breathing B. B. B.Tachypnea (with/without chest retractions) defined as per WHO /IMCI age specific criteria a)2 months to 12 months: Respiratory Rate > 50 b)12 months till 5 years: Respiratory Rate > 40 c) >5 years: Respiratory Rate >30

Exclusion criteria

Exclusion criteria: 1.Recurrent Pneumonia 2.Congenital Heart Disease 3.Severe Acute Malnutrition 4.Tuberculosis 5.Children on zinc supplements 6.Documented allergy /Intolerance to zinc 7.Chronic systemic illness 8.Congenital GI malformations 9.Hyper-reactive Airway Disease 10.Radiological findings inconsistent with diagnosis of pneumonia

Design outcomes

Primary

MeasureTime frame
To study the effect of oral zinc supplementation on time required for clinical recovery of pneumonia in pediatric patient.Timepoint: Till clinical recovery of pneumonia.

Secondary

MeasureTime frame
1.To study the effect of oral zinc supplementation on total number of days of hospitalization. Timepoint: Till discharge from hospital;To study the side effects of zinc.Timepoint: Till discharge from hospital

Countries

India

Contacts

Public ContactDr Kashmira Rajesh Mutha

Maharashtra University of Health Science

drtruptijoshi@gmail.com09503177911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026